RAMM Pharma (XCNQ:RAMM) 3-Year EBITDA Growth Rate : -29.50% (As of Jan. 2025)

View and export this data going back to 2019. Start your Free Trial

What is RAMM Pharma 3-Year EBITDA Growth Rate?

RAMM Pharma's EBITDA per Share for the three months ended in Jan. 2025 was C$-0.01.

During the past 3 years, the average EBITDA Per Share Growth Rate was -29.50% per year. During the past 5 years, the average EBITDA Per Share Growth Rate was -11.20% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the average EBITDA per share growth rate.

During the past 7 years, the highest 3-Year average EBITDA Per Share Growth Rate of RAMM Pharma was 9.00% per year. The lowest was -169.90% per year. And the median was -33.25% per year.

Competitive Comparison of RAMM Pharma's 3-Year EBITDA Growth Rate

For the Drug Manufacturers - Specialty & Generic subindustry, RAMM Pharma's 3-Year EBITDA Growth Rate, along with its competitors' market caps and 3-Year EBITDA Growth Rate data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

RAMM Pharma's 3-Year EBITDA Growth Rate Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, RAMM Pharma's 3-Year EBITDA Growth Rate distribution charts can be found below:

* The bar in red indicates where RAMM Pharma's 3-Year EBITDA Growth Rate falls into.

Save Embed

;

Save Embed

;

RAMM Pharma 3-Year EBITDA Growth Rate Calculation

This is the 3-year average growth rate of EBITDA per Share. The growth rate is calculated using exponential compounding based on the latest four year annual data.

Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the average EBITDA per share growth rate.

RAMM Pharma (XCNQ:RAMM) 3-Year EBITDA Growth Rate Explanation

EBITDA per Share is the amount of Earnings Before Interest, Taxes, Depreciation, and Amortization (EBITDA) per outstanding share of the company's stock.

Earnings Before Interest, Taxes, Depreciation, and Amortization (EBITDA) is what the company earns before it expenses interest, taxes, depreciation and amortization.

RAMM Pharma 3-Year EBITDA Growth Rate Related Terms

Thank you for viewing the detailed overview of RAMM Pharma's 3-Year EBITDA Growth Rate provided by GuruFocus.com. Please click on the following links to see related term pages.

RAMM Pharma Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » RAMM Pharma Corp (XCNQ:RAMM) » Definitions » 3-Year EBITDA Growth Rate

Comparable Companies

Traded in Other Exchanges

N/A

Address

82 Richmond Street E, Toronto, ON, CAN, M5C 1P1

Website

https://www.rammpharma.com

RAMM Pharma Corp is engaged in the pharmaceutical and medical product business, including cannabinoid pharmacology and product formulation for cannabis-based pharmaceuticals and other cannabis-based products. The group generates revenue from the sale of medical devices and consumables, the sale of pharmaceutical products, and sale of cosmetics. Geographically, it derives a majority of its revenue from Uruguay.

Executives

Jackie Peter Burnett	10% Security Holder, Director, Senior Officer
Armando Gabriel Blankleider	Director

RAMM Pharma Headlines

No Headlines